These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 24499557)

  • 1. Development and validation of automatic tools for interactive recurrence analysis in radiation therapy: optimization of treatment algorithms for locally advanced pancreatic cancer.
    Kessel KA; Habermehl D; Jäger A; Floca RO; Zhang L; Bendl R; Debus J; Combs SE
    Radiat Oncol; 2013 Jun; 8():138. PubMed ID: 24499557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Database supported electronic retrospective analyses in radiation oncology: establishing a workflow using the example of pancreatic cancer].
    Kessel KA; Habermehl D; Bohn C; Jäger A; Floca RO; Zhang L; Bougatf N; Bendl R; Debus J; Combs SE
    Strahlenther Onkol; 2012 Dec; 188(12):1119-24. PubMed ID: 23108385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic cancer adjuvant radiotherapy target volume design: based on the postoperative local recurrence spatial location.
    Yu W; Hu W; Shui Y; Zhu X; Li C; Ren X; Bai X; Yu R; Shen L; Liang T; Zheng L; Wei Q
    Radiat Oncol; 2016 Oct; 11(1):138. PubMed ID: 27756417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping patterns of local recurrence after pancreaticoduodenectomy for pancreatic adenocarcinoma: a new approach to adjuvant radiation field design.
    Dholakia AS; Kumar R; Raman SP; Moore JA; Ellsworth S; McNutt T; Laheru DA; Jaffee E; Cameron JL; Tran PT; Hobbs RF; Wolfgang CL; Herman JM
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1007-15. PubMed ID: 24267969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel four-dimensional radiotherapy planning strategy from a tumor-tracking beam's eye view.
    Li G; Cohen P; Xie H; Low D; Li D; Rimner A
    Phys Med Biol; 2012 Nov; 57(22):7579-98. PubMed ID: 23103415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of failure following high-dose 3-D conformal radiotherapy for high-grade astrocytomas: a quantitative dosimetric study.
    Lee SW; Fraass BA; Marsh LH; Herbort K; Gebarski SS; Martel MK; Radany EH; Lichter AS; Sandler HM
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):79-88. PubMed ID: 9989517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of treatment planning workflow and tumor coverage during daily adaptive magnetic resonance image guided radiation therapy (MR-IGRT) of pancreatic cancer.
    Olberg S; Green O; Cai B; Yang D; Rodriguez V; Zhang H; Kim JS; Parikh PJ; Mutic S; Park JC
    Radiat Oncol; 2018 Mar; 13(1):51. PubMed ID: 29573744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Origin of tumor recurrence after intensity modulated radiation therapy for oropharyngeal squamous cell carcinoma.
    Raktoe SA; Dehnad H; Raaijmakers CP; Braunius W; Terhaard CH
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):136-41. PubMed ID: 22541959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformity analysis to demonstrate reproducibility of target volumes for Margin-Intense Stereotactic Radiotherapy for borderline-resectable pancreatic cancer.
    Holyoake DL; Robinson M; Grose D; McIntosh D; Sebag-Montefiore D; Radhakrishna G; Patel N; Partridge M; Mukherjee S; Hawkins MA
    Radiother Oncol; 2016 Oct; 121(1):86-91. PubMed ID: 27519585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer.
    Dawson LA; Anzai Y; Marsh L; Martel MK; Paulino A; Ship JA; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2000 Mar; 46(5):1117-26. PubMed ID: 10725621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosimetric evaluation of simultaneous integrated boost during stereotactic body radiation therapy for pancreatic cancer.
    Yang W; Reznik R; Fraass BA; Nissen N; Hendifar A; Wachsman A; Sandler H; Tuli R
    Med Dosim; 2015; 40(1):47-52. PubMed ID: 25445989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pattern of failure after limited margin radiotherapy and temozolomide for glioblastoma.
    McDonald MW; Shu HK; Curran WJ; Crocker IR
    Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):130-6. PubMed ID: 20399036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-escalated radiotherapy for unresectable or locally recurrent pancreatic cancer: Dose volume analysis, toxicity and outcome of 28 consecutive patients.
    Zschaeck S; Blümke B; Wust P; Kaul D; Bahra M; Riess H; Klein F; Sinn M; Pelzer U; Budach V; Ghadjar P
    PLoS One; 2017; 12(10):e0186341. PubMed ID: 29023527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiotherapy technical considerations in the management of locally advanced pancreatic cancer: American-French consensus recommendations.
    Huguet F; Goodman KA; Azria D; Racadot S; Abrams RA
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1355-64. PubMed ID: 22768988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recommendations for MRI-based contouring of gross tumor volume and organs at risk for radiation therapy of pancreatic cancer.
    Heerkens HD; Hall WA; Li XA; Knechtges P; Dalah E; Paulson ES; van den Berg CAT; Meijer GJ; Koay EJ; Crane CH; Aitken K; van Vulpen M; Erickson BA
    Pract Radiat Oncol; 2017; 7(2):126-136. PubMed ID: 28089481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new delineation method research of the clinical target volume for pancreatic cancer adjuvant radiotherapy.
    Zhang TT; Wei L; Yuan GW; Zhao DQ; Zhang ML; Zhang GF; Wang PC
    Cancer Radiother; 2019 Jun; 23(3):201-208. PubMed ID: 31101540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase I/II trial of three-dimensionally planned concurrent boost radiotherapy and protracted venous infusion of 5-FU chemotherapy for locally advanced rectal carcinoma.
    Myerson RJ; Valentini V; Birnbaum EH; Cellini N; Coco C; Fleshman JW; Gambacorta MA; Genovesi D; Kodner IJ; Picus J; Ratkin GA; Read TE
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1299-308. PubMed ID: 11483342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retroperitoneal sarcoma (RPS) high risk gross tumor volume boost (HR GTV boost) contour delineation agreement among NRG sarcoma radiation and surgical oncologists.
    Baldini EH; Bosch W; Kane JM; Abrams RA; Salerno KE; Deville C; Raut CP; Petersen IA; Chen YL; Mullen JT; Millikan KW; Karakousis G; Kendrick ML; DeLaney TF; Wang D
    Ann Surg Oncol; 2015 Sep; 22(9):2846-52. PubMed ID: 26018727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of Failure in Patients With Head and Neck Squamous Cell Carcinomas of Unknown Primary Treated With Chemoradiotherapy.
    Dhouib F; Bertaut A; Maingon P; Siala W; Daoud J; Aubignac L; Lestrade L; Crehange G; Vulquin N
    Technol Cancer Res Treat; 2020; 19():1533033820905826. PubMed ID: 32484037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detailed evaluation of an automated approach to interactive optimization for volumetric modulated arc therapy plans.
    Tol JP; Dahele M; Delaney AR; Doornaert P; Slotman BJ; Verbakel WF
    Med Phys; 2016 Apr; 43(4):1818. PubMed ID: 27036579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.